Key terms

About NVST

Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. It operates through Specialty Products and Technologies, and Equipment and Consumables segments. The Specialty Products and Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment and Consumables segments develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems, handpieces and associated consumables, treatment units and other dental practice equipment, endodontic systems and related consumables, restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. It offers dental consumables, equipment, and services to dental professionals. The company was founded on August 29, 2018, and is headquartered in Brea, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest NVST news

Today 12:27am ET Envista Holdings: Navigating Leadership Changes and Long-Term Turnaround Challenges Apr 16 7:00am ET Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST), Nyxoah (NYXH) and Zoetis (ZTS) Apr 15 4:33pm ET Envista Holdings Hires New CEO Paul Keel; Aghdaei Resigns Apr 15 4:12pm ET Envista appoints Paul Keel as CEO Feb 27 6:00am ET Maintaining Hold on Envista Holdings Amidst Leadership Transition and Performance Uncertainties Feb 27 5:49am ET Envista Holdings: Strong Buy Rating Amid Leadership Transition and Future Profitability Prospects Feb 26 4:33pm ET Envista Holdings CEO Transition and Compensation Details Feb 26 4:11pm ET Envista announces planned CEO succession process Feb 26 7:55am ET Piper Sandler Keeps Their Hold Rating on Envista Holdings (NVST) Feb 26 6:26am ET Envista initiated with an Underperform at Leerink Feb 12 7:11am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Envista Holdings (NVST), Augmedix (AUGX) and Cochlear Limited (OtherCHEOF) Feb 11 9:10pm ET Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL) and Envista Holdings (NVST) Feb 09 5:33am ET Envista downgraded to Hold from Buy at Jefferies Feb 09 12:59am ET Hold Rating on Envista Holdings Amid Margin Pressures and Mixed Segment Performance Feb 08 8:32am ET Envista price target lowered to $23 from $24 at Piper Sandler Feb 08 7:39am ET Envista Holdings (NVST) Gets a Hold from Piper Sandler Feb 08 7:20am ET Analysts Are Bullish on These Healthcare Stocks: Pro Medicus Limited (PMCUF), Envista Holdings (NVST) Feb 08 7:09am ET Envista downgraded to Market Perform after earnings miss at William Blair Feb 08 7:05am ET Envista Holdings: Persistent Challenges Prompt Sell Rating Amid Downward EBITDA Revision Feb 08 6:40am ET Analysts Offer Insights on Healthcare Companies: CVS Health (CVS) and Envista Holdings (NVST) Feb 08 5:13am ET Envista downgraded to Market Perform from Outperform at William Blair Feb 07 4:24pm ET Envista sees FY24 core revenue up in low-single digits, consensus $2.59B Feb 07 4:23pm ET Envista reports Q4 adjusted EPS 29c, consensus 34c Jan 29 8:45am ET Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST), AbbVie (ABBV) and ESSA Pharma (EPIX)

NVST Financials

1-year income & revenue

Key terms

NVST Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

NVST Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms